Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jamaican Tech Report.
Press releases published on September 4, 2025
Bonafide® Health Announces Expansion to Retail with Exclusive Launch into 1,800+ Target Stores and Target.com
New York, NY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bonafide Health, LLC, a leading direct-to-consumer women’s healthcare company that provides clinically researched solutions to effectively relieve perimenopause …
Md Al Rafi Awarded Best Paper at IEEE RAICON 2024
Md Al Rafi ELLICOTT CITY, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Md Al Rafi has been awarded the Best Paper Award at the 2024 IEEE International Conference on Robotics, Automation, Artificial Intelligence and Internet-of-Things (RAICON), held in Dhaka, …
Artelo Biosciences Announces Pricing of $3.0 Million Public Offering
SOLANA BEACH, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …
Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver
VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a pioneering biotechnology company dedicated to revolutionizing addiction treatment and harm reduction solutions, today announced that its …
Alcatraz to Showcase Latest Biometric Security Innovations at Identity Week America 2025
CUPERTINO, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Alcatraz, the leader in facial biometric authentication for physical access, today announced its participation in Identity Week America 2025, where the company will showcase the latest enhancements to …
BiomX CEO to Present at H.C. Wainwright 27th Annual Global Investment Conference
NESS ZIONA, Israel, Sept. 04, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE), a clinical-stage company advancing natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that Jonathan Solomon, the Company’s …
Sofwave Receives FDA, Pre-market Clearance for Pure Impact VIPTM Standalone EMS Device For Comprehensive Multi-Body Area Muscle Strengthening and Firming
The Pure Impact VIP™ standalone device represents a major extension of the Pure Impact™ product line and introduces an all-in-one independent unit Standalone device is launched with an enhanced Pure Impact™ feature set which provides comprehensive muscle …
TONX (Formerly Verb) Exec Chairman Featured on CNBC ‘Squawk Box’ Asia
LAS VEGAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- TON Strategy Company (formerly Verb Technology Company Inc. VERB) (Nasdaq: TONX) (“TONX” or the “Company”), a digital asset treasury company committed to holding Toncoin ($TON), today announced that its …
Inuvo to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8th-10th
LITTLE ROCK, Ark., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, announced today that it will be participating in the H.C. Wainwright 27th Annual Global Investment …
U.S. Clean Energy Market Projected to Reach $198 Billion by 2033 Driven by Record Renewable Deployments & Advancing Technologies
PALM BEACH, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - A recent report from a Clean Energy industry insider said that: “The U.S. clean energy market is thriving, driven by record renewable deployments and advancing …
Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson’s Disease
Novel human preclinical neuronal model for Parkinson’s disease demonstrated CNM-Au8’s ability to improve mitochondrial health, restore cellular metabolism, reduce inflammation, and normalize dysregulated gene expression in both familial and sporadic …
Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base
Internationally recognized vascular surgeon, Dr. Koen Deloose provides patient access to latest innovative treatments and personalized care BERKELEY, Calif, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a …
CytoDyn Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
VANCOUVER, Washington, Sept. 04, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with …
Dr. Vuong Trieu, Developer of Novel Oncology and Immunotherapy Assets, Leads Oncotelic Therapeutics’ Commitment to Innovation, Life-Saving Therapies
Dr. Trieu’s prolific career includes multibillion-dollar drug discoveries targeting cancers of the breast, pancreas and non-small cell lung cancer, among others Oncotelic’s robust portfolio and clinical pipeline is supported by the innovations and …
Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management
NPM-139 has potential to provide Wegovy®-level efficacy with once or twice-yearly administration First-in-human Phase 1 study is expected to initiate in the first half of 2026, pending regulatory clearance Preparations for dose-ranging Phase 2 study of NPM …
Lexicon Pharmaceuticals to Present New Preclinical Data on Pilavapadin in Chemotherapy-Induced Pain and Multiple Sclerosis Pain at NeuPSIG 2025
THE WOODLANDS, Texas, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the Company will present new data demonstrating the reduction of neuropathic pain by pilavapadin in preclinical models of …
SEALSQ Accelerates Post-Quantum Readiness with Next-Generation TPMs Ahead of 2027 U.S. Government Deadline
Geneva, Switzerland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced …
Bright Minds Biosciences Announces BMB‑201 Outperforms Sumatriptan in Validated Preclinical Vascular Headache Model
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ: DRUG) today announced compelling preclinical results for its investigational compound BMB‑201, in a validated isosorbide dinitrate (ISDN) rat model of vascular headache. …
ZenaTech to Highlight Progress on Drone as a Service and US Defense Business at Multiple Upcoming Investor Conferences
VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), …
IO Biotech Announces Participation in Upcoming Investor Conferences
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, announced today that members of its senior management team …